Stockscreener 앱 받기
10.66
8.58%
-1.00
시간 외 거래:
10.66
Korro Bio Inc 주식(KRRO)의 최신 뉴스
Korro Bio: RNA Editor Plots Way Back After AATD Study FailI'm Holding (NASDAQ:KRRO) - Seeking Alpha
KRRO Q1 2026 Earnings: Narrowed Loss Surprises to the Upside, Shares RallyEarnings Surprise Stocks - newsline.com
KORRO BIO INC (KRRO) Stock Chart - ChartMill
Korro Bio Stockholders Approve Directors, Pay and Auditor - The Globe and Mail
Korro Bio (KRRO) director Ali Behbahani receives 14,677 stock options grant - Stock Titan
Korro Bio (KRRO) director receives 14,677 stock options at $10.59 strike - Stock Titan
Korro Bio (KRRO) director Nessan Bermingham receives 14,677 stock options at $10.59 - Stock Titan
Korro Bio (KRRO) director awarded 14,677 stock options at $10.59 strike price - Stock Titan
Director at Korro Bio (NASDAQ: KRRO) awarded stock options for 14,677 shares - Stock Titan
Korro Bio (NASDAQ: KRRO) director receives 14,677 stock options grant - Stock Titan
What makes Korro Bio, Inc. (KRRO) a new buy stock - MSN
Korro Bio (NASDAQ: KRRO) investors back directors, pay and auditor - Stock Titan
One Korro Bio Insider Raised Stake By 19% In Previous Year - Yahoo Finance
KRRO Q1 2026 Earnings: Narrower-than-expected loss drives positive surprise despite revenue absenceNext Quarter Guidance - newsline.com
KRRO Q1 2026 Earnings: EPS Beat But Stock Declines Amid No RevenueAnnual Report - newsline.com
KRRO Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline Amid Pre-Revenue PhaseManagement Tone Analysis - newsline.com
Korro Bio CEO Ram Aiyar sells $196,672 in company stock By Investing.com - Investing.com Nigeria
Korro Bio CEO Ram Aiyar sells $196,672 in company stock - Investing.com
Korro Bio Shares Slide 6% as Stock Tests Key Support LevelsTechnical Analysis - newsline.com
Korro Bio director sells $39,897 in common stock By Investing.com - Investing.com Canada
Korro Bio director sells $39,897 in common stock - Investing.com
Korro Bio Inc. (KRRO) Faces Selling Pressure as Shares Retreat 3.21%Bear Pennant - The Legal Advocate
KRRO Q1 2026 Earnings: EPS Beat by 10.05% as Biotech Advances PipelineNext Quarter Guidance - The Legal Advocate
Press Release: Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors - Moomoo
Piper Sandler Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Korro Bio, Inc. (KRRO) Reports Q3 Loss, Lags Revenue Estimates - MSN
Korro Bio | 4: Statement of changes in beneficial ownership of securities-Officer Aiyar Ram - Moomoo
Korro Bio, Inc. identifies surge in healthcare burden from ammonia in hepatic encephalopathy - Traders Union
Korro Bio (KRRO) Receives a Buy from H.C. Wainwright - The Globe and Mail
Korro to Present at the 2026 Jefferies Global Healthcare Conference - The Manila Times
H.C. Wainwright Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Korro Bio Stock Climbs Before Holiday; Bigger Test Still to Come - Bez Kabli
KRRO Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Stock ReactionPreliminary Results - newsline.com
Korro Bio Inc. (KRRO) Surges Nearly 12% as Biotech Momentum BuildsExpert Momentum Signals - Newser
Citigroup initiates coverage of Korro Bio (KRRO) with buy recommendation - MSN
Korro Bio Selects KRRO-111 as RNA Editing Therapy Candidate for Alpha-1 Antitrypsin Deficiency (AATD) with Best-in-Class Preclinical Results 1 – Minichart - minichart.com.sg
What is Korro Bio, Inc. (KRRO) stock_business overview_development history - Bitget
Korro Bio, Inc.Common Stock (NQ: KRRO - The Chronicle-Journal
Korro Bio adds AATD treatment candidate to pipeline By Investing.com - Investing.com South Africa
H.C. Wainwright cuts Korro Bio stock price target on financing impact By Investing.com - Investing.com South Africa
Korro Bio nominates new candidate for AATD - BioWorld News
H.C. Wainwright Maintains Korro Bio(KRRO.US) With Buy Rating, Cuts Target Price to $15 - Moomoo
Korro Bio, Inc. selects KRRO-111 after preclinical success in repairing AAT protein - Traders Union
H.C. Wainwright cuts Korro Bio stock price target on financing impact - Investing.com Nigeria
Korro Bio Advances KRRO-111 for Alpha-1 Deficiency - TipRanks
Korro Bio adds AATD treatment candidate to pipeline - Investing.com
KRRO Initiates Coverage by Citigroup -- Announces Buy Rating - GuruFocus
Citi Initiates Korro Bio(KRRO.US) With Buy Rating, Announces Target Price $21 - Moomoo
Lynx1 Capital Management LP's Korro Bio Inc(KRRO) Holding History - GuruFocus
1.27%
1.43%
자본화:
|
볼륨(24시간):